Clinical Trial Update: Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients? [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether alendronate can suppress calcification and improve bone density in patients with end-stage renal disease on chronic peritoneal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: End-Stage Renal Disease, Osteoporosis | Phase 4 | Status: COMPLETED